PayPal Can't Catch A Break As Even A Triple Beat Leaves Investors Asking For More — Positive
PYPL Seeking Alpha — July 29, 2025PayPal Holdings Inc. just reported a triple beat for their Q2 FY 2025 earnings and the stock is down -9%. Revenue growth from Braintree is reaccelerating, active accounts are growing again, they're improving their profitability. At the same times, valuations remain incredibly depressed, not pricing in any type of success from all the projects PayPal has been announcing lately.
Acadia Realty Trust (AKR) Q2 FFO Miss Estimates — Negative
AKR Zacks Investment Research — July 29, 2025Acadia Realty Trust (AKR) came out with quarterly funds from operations (FFO) of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to FFO of $0.31 per share a year ago.
Global Industrial (GIC) Q2 Earnings and Revenues Surpass Estimates — Positive
GIC Zacks Investment Research — July 29, 2025Global Industrial (GIC) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.52 per share a year ago.
Houlihan Lokey (HLI) Q1 Earnings and Revenues Top Estimates — Positive
HLI Zacks Investment Research — July 29, 2025Houlihan Lokey (HLI) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $1.22 per share a year ago.
Nabors Industries (NBR) Reports Q2 Loss, Tops Revenue Estimates — Negative
NBR Zacks Investment Research — July 29, 2025Nabors Industries (NBR) came out with a quarterly loss of $2.71 per share versus the Zacks Consensus Estimate of a loss of $2.05. This compares to a loss of $4.29 per share a year ago.
RE/MAX (RMAX) Surpasses Q2 Earnings Estimates — Positive
RMAX Zacks Investment Research — July 29, 2025RE/MAX (RMAX) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.41 per share a year ago.
Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates — Positive
AMED Zacks Investment Research — July 29, 2025Amedisys (AMED) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.32 per share a year ago.
Navios Maritime Partners LP (NMM) Falls More Steeply Than Broader Market: What Investors Need to Know — Neutral
NMM Zacks Investment Research — July 29, 2025Navios Maritime Partners LP (NMM) reached $42.42 at the closing of the latest trading day, reflecting a -1.07% change compared to its last close.
Kadant (KAI) Beats Q2 Earnings and Revenue Estimates — Positive
KAI Zacks Investment Research — July 29, 2025Kadant (KAI) came out with quarterly earnings of $2.31 per share, beating the Zacks Consensus Estimate of $1.94 per share. This compares to earnings of $2.81 per share a year ago.
InvenTrust Properties Corp. (IVT) Q2 FFO Lag Estimates — Negative
IVT Zacks Investment Research — July 29, 2025InvenTrust Properties Corp. (IVT) came out with quarterly funds from operations (FFO) of $0.44 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to FFO of $0.43 per share a year ago.
Pebblebrook Hotel (PEB) Q2 FFO and Revenues Beat Estimates — Positive
PEB Zacks Investment Research — July 29, 2025Pebblebrook Hotel (PEB) came out with quarterly funds from operations (FFO) of $0.65 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to FFO of $0.69 per share a year ago.
SharkNinja, Inc. (SN) Suffers a Larger Drop Than the General Market: Key Insights — Negative
SN Zacks Investment Research — July 29, 2025In the most recent trading session, SharkNinja, Inc. (SN) closed at $118.55, indicating a -1.22% shift from the previous trading day.
Axon Enterprise (AXON) Sees a More Significant Dip Than Broader Market: Some Facts to Know — Neutral
AXON Zacks Investment Research — July 29, 2025Axon Enterprise (AXON) closed at $728.74 in the latest trading session, marking a -1.03% move from the prior day.
Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note — Neutral
VRTX Zacks Investment Research — July 29, 2025Vertex Pharmaceuticals (VRTX) closed at $468.41 in the latest trading session, marking a +1.64% move from the prior day.
Tutor Perini (TPC) Declines More Than Market: Some Information for Investors — Neutral
TPC Zacks Investment Research — July 29, 2025In the most recent trading session, Tutor Perini (TPC) closed at $46.91, indicating a -1.51% shift from the previous trading day.
Adma Biologics (ADMA) Rises As Market Takes a Dip: Key Facts — Neutral
ADMA Zacks Investment Research — July 29, 2025The latest trading day saw Adma Biologics (ADMA) settling at $18.26, representing a +1.44% change from its previous close.
Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today — Neutral
RXRX Zacks Investment Research — July 29, 2025In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.95, marking a -5.71% move from the previous day.
Here's Why DXP Enterprises (DXPE) Fell More Than Broader Market — Negative
DXPE Zacks Investment Research — July 29, 2025DXP Enterprises (DXPE) reached $110.53 at the closing of the latest trading day, reflecting a -1.1% change compared to its last close.
Macy's (M) Sees a More Significant Dip Than Broader Market: Some Facts to Know — Neutral
M Zacks Investment Research — July 29, 2025In the latest trading session, Macy's (M) closed at $13.31, marking a -2.99% move from the previous day.
Why Blue Bird (BLBD) Dipped More Than Broader Market Today — Neutral
BLBD Zacks Investment Research — July 29, 2025Blue Bird (BLBD) closed at $45.26 in the latest trading session, marking a -1.86% move from the prior day.
